New Delhi, May 23 -- Shares of Emcure Pharmaceuticals were locked in a 10 percent upper circuit at Rs.1,288.65 on Friday, May 23, as the stock extended its rally for a second straight session. The rally comes on the back of a strong performance for the quarter ended March 2025 (Q4FY25). The stock had already surged nearly 9 percent in the previous session, taking its total two-day gain to about 20 percent.

As of the March 2025 quarter, Shark Tank judge Namita Vikas Thapar owns 50.71 lakh share or a 2.68 percent stake of the firm.

Emcure reported a 64 percent year-on-year (YoY) jump in consolidated net profit to Rs.189 crore in Q4FY25, compared to Rs.115 crore in the same quarter last year. The revenue from operations rose 20 percent YoY...